Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lázaro Gil

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|September 12, 2019
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?Iris Valdés, Laura Lazo, Lisset Hermida, et al.
Expert Review of Vaccines|January 25, 2019
Aiming at the heart: the capsid protein of dengue virus as a vaccine candidateLaura Lazo, Iris Valdes, Gerardo Guillén, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|November 30, 2022
Homogeneous ferrous iron oxidation in a pilot-scale electrocoagulation system treating municipal wastewater: a model validation and simulation studyJimena Lázaro Gil, Paula van den Brink, Peter De Moel, et al.
Archives of Virology|February 22, 2012
The serogroup A capsular polysaccharide from Neisseria meningitidis enhances the cell-mediated immunity and the protective capacity induced by a dengue fusion protein in miceLisset Hermida, Iris Valdés, Lázaro Gil, et al.
Archives of Virology|November 22, 2015
Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?Iris Valdés, Lázaro Gil, Laura Lazo, et al.
Viral Immunology|February 13, 2009
The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis modelLázaro Gil, Carlos López, Aracelys Blanco, et al.
Archives of Virology|May 21, 2014
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in miceAlienys Izquierdo, Angélica García, Laura Lazo, et al.
Antiviral Research|May 5, 2012
Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2Alienys Izquierdo, Iris Valdés, Lázaro Gil, et al.
Clinical and Vaccine Immunology : CVI|January 7, 2011
The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2Iris Valdés, Lázaro Gil, Yaremis Romero, et al.
Acta Tropica|July 4, 2012
A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in miceLaura Lazo, Lázaro Gil, Carlos López, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|September 12, 2019
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?Iris Valdés, Laura Lazo, Lisset Hermida, et al.
Expert Review of Vaccines|January 25, 2019
Aiming at the heart: the capsid protein of dengue virus as a vaccine candidateLaura Lazo, Iris Valdes, Gerardo Guillén, et al.
Water Science and Technology : a Journal of the International Association on Water Pollution Research|November 30, 2022
Homogeneous ferrous iron oxidation in a pilot-scale electrocoagulation system treating municipal wastewater: a model validation and simulation studyJimena Lázaro Gil, Paula van den Brink, Peter De Moel, et al.
Archives of Virology|February 22, 2012
The serogroup A capsular polysaccharide from Neisseria meningitidis enhances the cell-mediated immunity and the protective capacity induced by a dengue fusion protein in miceLisset Hermida, Iris Valdés, Lázaro Gil, et al.
Archives of Virology|November 22, 2015
Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?Iris Valdés, Lázaro Gil, Laura Lazo, et al.
Viral Immunology|February 13, 2009
The cellular immune response plays an important role in protecting against dengue virus in the mouse encephalitis modelLázaro Gil, Carlos López, Aracelys Blanco, et al.
Archives of Virology|May 21, 2014
A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in miceAlienys Izquierdo, Angélica García, Laura Lazo, et al.
Antiviral Research|May 5, 2012
Serotype specificity of recombinant fusion protein containing domain III and capsid protein of dengue virus 2Alienys Izquierdo, Iris Valdés, Lázaro Gil, et al.
Clinical and Vaccine Immunology : CVI|January 7, 2011
The chimeric protein domain III-capsid of dengue virus serotype 2 (DEN-2) successfully boosts neutralizing antibodies generated in monkeys upon infection with DEN-2Iris Valdés, Lázaro Gil, Yaremis Romero, et al.
Acta Tropica|July 4, 2012
A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in miceLaura Lazo, Lázaro Gil, Carlos López, et al.
Pageof 4